Noninvasive diagnostic tests for NAFLD: Accuracy without the agony
08 Sep 2020
Non-alcoholic fatty liver disease (NAFLD) is characterized by steatosis, liver cell injury and inflammation. It is rapidly becoming the most common liver disease worldwide. Its prevalence in Asia is increasing which is attributed to the increased metabolic risk factors including obesity, diabetes and metabolic syndrome. In a Sanofi-sponsored symposium during the Philippine Liver Meeting of The Hepatology Society of the Philippines at the EDSA Shangri-la Hotel, Mandaluyong City on 22 January 2020, Dr Jose Sollano Jr., Gastroenterologist at the Asian Hospital and Medical Center, explored the diagnostic approach to assess the severity of NAFLD and discussed the available noninvasive diagnostic tests to assess patients suspected with NAFLD.